Cover Image
Market Research Report

Single Cell Genomics Markets Forecasts by End User & Technology. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2020 to 2024

Published by Howe Sound Research Product code 855452
Published Content info 225 Pages
Delivery time: 1-2 business days
Price
Back to Top
Single Cell Genomics Markets Forecasts by End User & Technology. With Executive and Consultant Guides and including Customized Forecasting and Analysis. 2020 to 2024
Published: November 2, 2019 Content info: 225 Pages
Description

OVERVIEW:

Single Cell Genomics is emerging as a mainstay of scientific research and development. Just coming out of the lab it is finding its footing in new clinical applications especially related to immune-oncology and microbiology. But the largest market is still in research and the market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School
Table of Contents

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 What is Single Cell Genomics?
  • 1.2 SCG - Still Early Days
    • 1.3 Market Definition
    • 1.3.1 Market Size
    • 1.3.2 Currency
    • 1.3.3 Years
  • 1.4 Methodology
    • 1.4.1 Authors
    • 1.4.2 Sources
  • 1.5 Sizing the Genome - Not What You Think
    • 1.5.1 Cost, Price and Genome Size, Pricing Practice
  • 1.6 GLOBAL LISTING OF HIGH THROUGHPUT SEQUENCING ESTABLISHMENTS INSTALLED BASE - Location & Contacts

2. Single Cell Genomice - Guide to Technology

  • 2.1 Isolating Single Cells
    • 2.1.1 FACS
    • 2.1.2 LCM
    • 2.1.3 Micromanipulators
    • 2.1.4 Microfluidics
  • 2.2 Amplification
    • 2.2.1 WTA - Whole Transcriptome Amplification
    • 2.2.2 WGA - Whole Genome Amplification
  • 2.3 PCR
  • 2.4 NGS
  • 2.5 Microarray
  • 2.6 Digital Spatial Profiling (DSP) Technology

3. Industry Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Genomic Instrumentation Supplier
    • 3.1.3 Cell Separation and Viewing Instrumentation Supplier
    • 3.1.4 Cell Line and Reagent Supplier
    • 3.1.5 Pharmaceutical or Reagent Company
    • 3.1.6 Audit Body
    • 3.1.7 Certification Body

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Immuno-oncology
    • 4.1.2 Research Range
    • 4.1.3 Technology Maturity & Convergence
    • 4.1.4 Declining Costs
  • 4.2 Factors Limiting Growth
    • 4.2.1 Competition
    • 4.2.2 Instrument Integration
    • 4.2.3 Technology Shift
    • 4.2.4 Technology Limitations
  • 4.3 Technology Development
    • 4.3.1 Spatial Profiling
    • 4.3.2 Integration
    • 4.3.3 Big Data
    • 4.3.4 Kits and Commodities

5. Single Cell Genomics Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
      • Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology
      • 10x Genomics Expects $271M In Proceeds
      • Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance
      • Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Fronts
      • Bio-Rad Launches its Single Cell scATAC-Seq Solution
      • 10x Genomics Acquires Spatial Transcriptomics
      • Takara Bio strengthens its IP position on single cell RNA-seq
      • Mission Bio Launches Tapestri® for Targeted Single-Cell DNA Custom Panels
      • SingulOmics Detects Somatic Single Nucleotide Variations in Single Cells
      • 1CELLBIO and OMI to validate Single Cell Analysis for Personalized Medicine
      • Sony MA900 Cell Sorter Nominated
      • UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV
      • Diagnostic Assay
      • Bio-Rad's dd-PCR tests for leukemia cleared
      • IncellDx's Single Cell Immuno-Oncology/PD-L1 Technology used in new Cancer Assay
      • Cytena GmbH land EUR 3M in Series A
      • NanoString Announces Launch of CAR-T Panel
      • Dolomite Bio launches high throughput single nuclei profiling on Nadia platform
      • Silicon Biosystems Develops New Assay for Circulating Multiple Myeloma Cells

6. Profiles of Key Single Cell Genomics Companies

  • 10x Genomics
  • 1CellBio
  • Agilent
  • Beckman Coulter
  • Becton Dickinson
  • Bio-Rad
  • Bruker
  • Cell Microsystems
  • Cellsee Diagnostics
  • CellSorter
  • Cytena
  • CytoTrack
  • Dolomite Bio
  • Fluidigm
  • Fluxion Biosciences
  • Illumina
  • IncellDx
  • Labcyte
  • Leica Microsystems
  • Miltenyi Biotec
  • Mission Bio
  • Oxford Nanopore Technologies
  • NanoString
  • Perkin Elmer
  • Qiagen
  • Readcoor
  • Silicon Biosystems
  • Singulomics
  • Sony
  • Takara Bio
  • Thermo Fisher
  • Watchmaker Genomics

7. Global Market Size

  • 7.1 Single Cell Genomics Global Market Size by Country with Charts
  • 7.2 Single Cell Genomics Global Market Size by Sequencing Technology with Charts

8. Global Market by Technology

  • 8.1 PCR Market
    • 8.1.1 PCR Market by Country with Chart
  • 8.2 qPCR Market
    • 8.2.1 qPCR Market by Country with Chart
  • 8.3 NGS Market
    • 8.3.1 NGSMarket by Country with Chart
  • 8.4 Microarray Market
    • 8.4.1 Microarray Market by Country with Chart
  • 8.5 Other Technology Market
    • 8.5.1 Other Technology Market by Country with Chart

9. Cell Based Assay by End User

  • 9.1 Research Market
    • 9.1.1 Research Market by Country with Chart
  • 9.2 BioPharma Market
    • 9.2.1 BioPharma Market by Country with Chart
  • 9.3 Clinical Market
    • 9.3.1 Clinical Market by Country with Chart
  • 9.4 Other End User Market
    • 9.4.1 Other End User Market by Country with Chart

10. Appendices

  • 10.1 FDA Cancer Drug Approvals by Year
  • 10.2 Clinical Trials Started 2010 to 2016
  • 10.3 Prevalence of Cancer Treatments - 2015

Table of Tables

  • Table 1 Global List of Gene Sequencing Facilities
  • Table 2 Cell Isolation Overview
  • Table 3 Market Players by Type
  • Table 4 Five Factors Driving Growth
  • Table 5 Three Factors Limiting Growth
  • Table 6 Single Cell Genomics Global Market by Country/Region
  • Table 7 Single Cell Genomics Global Market by Technology
  • Table 8 PCR Market by Country
  • Table 9 qPCR Market by Country
  • Table 10 NGS Market by Country
  • Table 11 Microarray Market by Country
  • Table 12 Other Technology Market by Country
  • Table 13 Research Market by Country
  • Table 14 BioPharma Market by Country
  • Table 15 Clinical Market by Country
  • Table 16 Other End User Market by Country

Table of Figures

  • Figure 1 Size of Different Genomes
  • Figure 2 flourescence Activated Sorter
  • Figure 4 Market Size by Country - Key Countries
  • Figure 5 Chart of Global Market by Sequebcing Technology
  • Figure 6 Single Cell Genomics Share Change by Technology
  • Figure 7 Chart - PCR Market Growth
  • Figure 8 Chart qPCR Market Growth
  • Figure 9 Chart - NGS Market Growth
  • Figure 10 Chart - Microarray Market Growth
  • Figure 11 Chart - Other Technology Market Growth
  • Figure 12 Chart - Research Market Growth
  • Figure 13 Chart - BioPharma Market Growth
  • Figure 14 Chart - Clinical Market by Growth
  • Figure 15 Chart - Other End User Market Growth
  • Figure 16 FDA Cancer Drug Approvals by Year
  • Figure 17 Clinical Trials for Immunotherapy by Year
  • Figure 18 Pie Chart of Prevalence of Cancer Treatments
Back to Top